In the gut, the activation of CCL2/CCR2 pathway has been described in several experimental colitis models (Yang et al., 2011) whereas CCL2 levels are increased in the colon of patients suffering from microscopic colitis and inflammatory bowel diseases (Arijs et al., 2011; Günaltay et al., 2015). Here, CCR2 is linked to inflammatory bowel disease.